118 related articles for article (PubMed ID: 4213051)
1. Editorial: Therapy in genetic disease.
Erbe RW
N Engl J Med; 1974 Nov; 291(19):1028-9. PubMed ID: 4213051
[No Abstract] [Full Text] [Related]
2. Enzyme replacement therapy in Gaucher's and Fabry's disease.
Pentchev PG
Ann Clin Lab Sci; 1977; 7(3):251-3. PubMed ID: 404951
[TBL] [Abstract][Full Text] [Related]
3. An appraisal of human trials in enzyme replacement therapy of genetic diseases.
Tager JM; Hamers MN; Schram AW; Van den Bergh FA; Rietra PJ; Loonen C; Koster JF; Slee R
Birth Defects Orig Artic Ser; 1980; 16(1):343-59. PubMed ID: 6778527
[No Abstract] [Full Text] [Related]
4. Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.
Brady RO; Pentchev PG; Gal AE; Hibbert SR; Dekaban AS
N Engl J Med; 1974 Nov; 291(19):989-93. PubMed ID: 4415565
[No Abstract] [Full Text] [Related]
5. Further developments in studies in sphingolipidoses: "missing enzymes".
Brady RO
Riv Patol Nerv Ment; 1970 Oct; 91(5):263-73. PubMed ID: 5525771
[No Abstract] [Full Text] [Related]
6. The lipid storage diseases: new concepts and control.
Brady RO
Ann Intern Med; 1975 Feb; 82(2):257-61. PubMed ID: 163609
[TBL] [Abstract][Full Text] [Related]
7. An enzymological approach to the lipidoses.
Tallman JF; Pentchev PG; Brady RO
Enzyme; 1974; 18(1):136-49. PubMed ID: 4211795
[No Abstract] [Full Text] [Related]
8. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.
Brady RO; Tallman JF; Johnson WG; Gal AE; Leahy WR; Quirk JM; Dekaban AS
N Engl J Med; 1973 Jul; 289(1):9-14. PubMed ID: 4196713
[No Abstract] [Full Text] [Related]
9. Genetic disorders of lysosomes.
Hirschhorn R; Weissmann G
Prog Med Genet; 1976; 1():49-101. PubMed ID: 180565
[No Abstract] [Full Text] [Related]
10. [Sphingolipidoses. Biochemistry and enzymatic mechanisms].
Gajdos A
Nouv Presse Med; 1972 Jun; 1(26):1789-92. PubMed ID: 5054020
[No Abstract] [Full Text] [Related]
11. [Recent acquisitions in sphingolipidosis].
Durand P
Minerva Pediatr; 1970 Jun; 22(24):1233-7. PubMed ID: 5515760
[No Abstract] [Full Text] [Related]
12. Repacement therapy in Gaucher disease.
Beutler E; Dale GL; Kuhl W
Birth Defects Orig Artic Ser; 1980; 16(1):369-81. PubMed ID: 6778528
[No Abstract] [Full Text] [Related]
13. Quantity and fatty acyl composition of the glycosphingolipids of Gaucher spleen.
Kuske TT; Rosenberg A
J Lab Clin Med; 1972 Oct; 80(4):523-9. PubMed ID: 4342231
[No Abstract] [Full Text] [Related]
14. [Biochemical aspects of sphingolipidosis].
Douste-Blazy L; Thouvenot JP
Ann Biol Clin (Paris); 1972; 30(6):623-35. PubMed ID: 4569435
[No Abstract] [Full Text] [Related]
15. Investigations in enzyme replacement therapy in lipid storage diseases.
Brady RO; Pentchev PG; Gal AG
Fed Proc; 1975 Apr; 34(5):1310-5. PubMed ID: 804420
[TBL] [Abstract][Full Text] [Related]
16. Chemical chaperones--a new concept in drug research.
Kolter T; Wendeler M
Chembiochem; 2003 Apr; 4(4):260-4. PubMed ID: 12672104
[No Abstract] [Full Text] [Related]
17. Enzyme therapy for inborn errors of metabolism.
Desnick RJ; Bernlohr RW; Krivit W
Postgrad Med; 1973 Jan; 53(1):214-6. PubMed ID: 4508960
[No Abstract] [Full Text] [Related]
18. Renal transplantation in Type II Gaucher disease.
Desnick SJ; Desnick RJ; Brady RO; Pentchev PG; Simmons RL; Najarian JS; Swaiman K; Sharp HL; Krivit W
Birth Defects Orig Artic Ser; 1973 Mar; 9(2):109-19. PubMed ID: 4611522
[No Abstract] [Full Text] [Related]
19. Diagnostic and therapeutic applications of sphingolipid hydrolyzing enzymes.
Brady RO
Curr Top Cell Regul; 1985; 26():39-50. PubMed ID: 3935381
[No Abstract] [Full Text] [Related]
20. Enzyme replacement in Fabry disease: treatment of cultured skin fibroblasts with a purified alpha-galactosidase from ficin.
Dawson G; Matalon R; Li YT
Birth Defects Orig Artic Ser; 1973 Mar; 9(2):97-101. PubMed ID: 4215480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
